Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125527341 | 12552734 | 1 | I | 2016 | 20160706 | 20160713 | 20160713 | PER | US-009507513-1607USA002573 | MERCK | 25.00 | YR | F | Y | 64.40000 | KG | 20160713 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125527341 | 12552734 | 1 | PS | NUVARING | ETHINYL ESTRADIOLETONOGESTREL | 1 | Vaginal | UNK | 21187 | VAGINAL RING | |||||||||
| 125527341 | 12552734 | 2 | SS | NUVARING | ETHINYL ESTRADIOLETONOGESTREL | 1 | 21187 | VAGINAL RING |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125527341 | 12552734 | 1 | Contraception |
| 125527341 | 12552734 | 2 | Polycystic ovaries |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125527341 | 12552734 | Menorrhagia | |
| 125527341 | 12552734 | Muscle spasms | |
| 125527341 | 12552734 | Product use issue | |
| 125527341 | 12552734 | Vaginal haemorrhage |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125527341 | 12552734 | 1 | 201606 | 0 |